SYRE Net Income Growth
Spyre Therapeutics Inc · Net Income Growth
SYRE Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported13.49%period ending
SYRE TTM Net Income YoY % (-9.16% → 13.49%)
Year-over-year change
High-resolution chart · PNG
SYRE net income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Net Income Growth |
|---|---|
| 13.4884% | |
| 14.1188% | |
| 25.3896% | |
| 30.6805% | |
| -11.2017% | |
| 42.636% | |
| 38.5997% | |
| 27.0113% | |
| 31.7649% | |
| -368.1495% | |
| -304.2117% | |
| -244.6108% | |
| -211.4533% | |
| -8.0284% | |
| -27.3765% | |
| -25.5182% | |
| -33.0071% | |
| 10.4052% | |
| 18.6567% | |
| 14.5656% | |
| 20.9328% | |
| -0.7116% | |
| -3.3724% | |
| -11.188% | |
| -34.214% | |
| -49.4775% | |
| -76.4544% | |
| -99.4184% | |
| -94.4214% | |
| -83.441% | |
| -62.8286% | |
| -36.9607% | |
| -29.6341% | |
| -24.4038% | |
| -25.5231% | |
| -29.8683% | |
| -41.5664% | |
| -74.9514% | |
| -92.1027% | |
| -92.6018% | |
| -68.2839% | |
| -18.4064% | |
| -9.1621% |